1Centers for Disease Control and Prevention. Update on influenza A (H1N1) 2009 monovalent vaccines [J]. MMWR, 2009, 58(39) : 1100-1101.
2Centers for Disease Control and Prevention. Safety of influenza A (H1NI) 2009 monovalent vaccines [ J ]. MMWR, 2009, 58(1) : 1-6.
3Poland GA, Dennis M, Ruben B-G. New vaccine development [J]. BMJ, 2002, 324(7349):1315-1319.
4Tuteja. DNA vaccines : A ray of hope [ J ]. Crit Rev Biochem Mol Biol, 1999, 34(1) : 1-24.
5Lu S, Wang S, Grimes-Serrano JM. Current progress of DNA vaccine studies in humans [ J ]. Expert Rev Vaccine, 2008, 7(2) : 175-191.
6Lee C J, Lee LH, Gu XX. Mucosal immunity induced by pneumococcal glycoconjugate [ J ]. Crit Rev Microhiol, 2005, 31(3) : 137-144.
7Yu JR, Kim S, Lee JB, et al. Single intranasal immunization with recombinant adenovirus-based vaccine induces prolective immunity against respiratory syncytial virus infection [J].J Virol, 2008, 82(5) : 2350-2357.
8Shoemaker DR, Saunders NB, Brandt BL, et al. Intranasal delivery of group B meningococcal native outer membrane vesicle vaccine induces local mucosal and serum bactericidal antibody responses in rabbits [ J ]. Infect Immun, 2005,73(8) : 5031-5038.
9Zepp F, Schmitt H J, Cleerbout J, et al. Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine) [ J ]. Expert Rev Vaccines, 2009, 8(6) : 673-678.
10Kabir S. The current status of Helicobacter pylori vaccines : A review[J].Helicobacter, 2007, 12(2) : 89-102.
